Skip to content

Envoy Medical COCH Depreciation

Depreciation at other companies

GATX logo
GATXGATX
$169.2M+63.3%
Skyline Champion logo
Skyline ChampionSKY
$9.02M+9.6%
Adient logo
AdientADNT
-$68M-1.5%
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
$3K
Kyndryl Holdings logo
Kyndryl HoldingsKD
$183.25M+18.6%
S&P Global logo
S&P GlobalSPGI
$31M+24.0%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's depreciation?
Envoy Medical (COCH) reported depreciation of $73K in Q1 2026.
How has Envoy Medical's depreciation changed year-over-year?
Envoy Medical's depreciation increased by 19.7% year-over-year, from $61K to $73K.
What is the long-term trend for Envoy Medical's depreciation?
Over 2 years (2023 to 2025), Envoy Medical's depreciation has grown at a 50.7% compound annual growth rate (CAGR), from $133K to $302K.